EXOZ Exercise Disclosure
Perriman Damien Alan · SEC Form 4 · Filed Oct 26, 2026
Exercise
Reported value range
Not reported
Perriman Damien Alan Chief Commercial Officer
EXOZ
Exozymes Inc.
EXOZ
Transaction date
Oct 9, 2026
Public filing date
Oct 26, 2026
Filing lag
Filed 17 days later
EXOZ daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,922 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-048493
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$19.43K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Exozymes Inc. EXOZ | Sale | Oct 12, 2026 | $19.43K |
| Exozymes Inc. EXOZ Current | Exercise | Oct 9, 2026 | Not reported |
| Exozymes Inc. EXOZ | Exercise | Oct 9, 2026 | $0 |